ResearcherUniversity of CopenhagenActive in the last 2 years
Lars Nannestad Jørgensen
Matched on ORCID iD 0000-0001-7465-5374; OpenAlex author ID A5020717767. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 7
- BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target. Co-author DOI 10.1038/s41598-025-24463-0↗
- Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ducta… Co-author DOI 10.1186/s12885-025-14283-w↗
- High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fmolb.2023.1158058↗
- Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibro… Co-author DOI 10.3390/biom12091315↗
- Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Co-author DOI 10.3390/cells11233763↗
- Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenoc… Co-author DOI 10.1002/ijc.33551↗
- The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review. Last author DOI 10.1016/j.ejca.2021.05.033↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hadi M. H. Diab · 7 shared papers, 2021–2025 · strength 1.18
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A … DOI 10.1016/j.ejca.2021.05.033↗
- M.A. Karsdal · 6 shared papers, 2021–2025 · strength 0.98
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Nicholas Willumsen · 6 shared papers, 2021–2025 · strength 0.98
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Julia Sidenius Johansen · 6 shared papers, 2021–2025 · strength 0.98
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Inna Markovna Chen · 6 shared papers, 2021–2025 · strength 0.98
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Neel Ingemann Nissen · 5 shared papers, 2021–2025 · strength 0.76
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Carsten Palnæs Hansen · 4 shared papers, 2022–2025 · strength 0.67
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Rasmus S. Pedersen · 3 shared papers, 2022–2025 · strength 0.56
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarci… DOI 10.3390/biom12091315↗
- Emilie A. Madsen · 2 shared papers, 2022–2023 · strength 0.31
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in P… DOI 10.3390/cells11233763↗
- Astrid Zedlitz Johansen · 2 shared papers, 2021–2023 · strength 0.28
- Paper High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients … DOI 10.3389/fmolb.2023.1158058↗
- Paper Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) i… DOI 10.1002/ijc.33551↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.